Innoviva Inc (INVA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.31B
Last updated: Nov 17, 2026 at 4:15 PM ET
Innoviva Inc (INVA) Stock Chart
Innoviva (INVA) has a latest price of $18.30 on Nov 17, 2026. Its price fell 17.8% over the past 12 months. The month-end price rose 106.0% over the 10 years through Oct 2026, a compound annual rate of 7.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $23.30 in Mar 2026 and its lowest $10.30 in Oct 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart INVA with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for INVA.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 14.8%, and over 6 months it fell 15.8%. The month-end price rose 71.0% over the 3 years through Oct 2026, a compound annual rate of 19.6%.
| Period | Change |
|---|---|
| 1 month | -13.2% |
| 3 months | -14.8% |
| 6 months | -15.8% |
| 12 months | -17.8% |
| 12 months, with dividends | -17.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +71.0% | +19.6% |
| 5 years | +21.6% | +4.0% |
| 10 years | +106.0% | +7.5% |
Price by Year
Its best calendar year was 2021, when the price rose 39.2%, and its weakest was 2022, when it fell 23.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $21.22 | +6.2% |
| 2025 | $19.99 | +15.2% |
| 2024 | $17.35 | +8.2% |
| 2023 | $16.04 | +21.1% |
| 2022 | $13.25 | -23.2% |
| 2021 | $17.25 | +39.2% |
| 2020 | $12.39 | -12.5% |
| 2019 | $14.16 | -18.9% |
| 2018 | $17.45 | +23.0% |
| 2017 | $14.19 | +32.6% |
Trading Range
The price is 11.1% below its 50-day average of $20.58 and 16.3% below its 200-day average of $21.87.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $18.30 | |
| 50-day average | $20.58 | -11.1% |
| 200-day average | $21.87 | -16.3% |
Price Risk
Over 3 years, its largest fall from a peak was 24.5%.
| Measure | Value |
|---|---|
| 1-year beta | 0.34 |
| Largest fall, 1 year | -24.5% |
| Largest fall, 3 years | -24.5% |
Valuation
Innoviva traded at 6.6x earnings at the end of 2025, against a 5-year median of 10.7x and a 10-year median of 9.1x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About INVA
What is INVA's 1-year price change?
Innoviva's price fell 17.8% over the past 12 months. With dividends included, the 12-month total return was -17.8%.
What is INVA's 5-year price change?
Innoviva's month-end price rose 21.6% over the 5 years through Oct 2026, a compound annual rate of 4.0%. These figures leave out dividends.
What is INVA's beta?
Innoviva's 1-year beta against the S&P 500 is 0.34, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 24.5%.
Is the INVA chart free?
Yes. Advanced Charting for INVA is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
INVA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors